<p>The Platinum Study is an R01-funded, multicenter study of testicular cancer survivors that characterizes both long-term cisplatin-induced peripheral neuropathy (CisIPN) and cisplatin-associated ototoxicity, i.e., permanent, bilateral hearing loss. We collected data abstracted from medical records (e.g., cumulative cisplatin dose), conducted audiometric examinations, and administered self-report questionnaires, which included CisIPN symptoms. </p>

The Platinum Study

Cisplatin study with SNP Genotypes (Array), SNP Genotypes (imputed) data on dbGaP (680 participants)

The Platinum Study

Description

Applying For Access

Summary